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Abstract
Objective The objective of this study is to assess the outcome of liver resections in the elderly in a matched control analysis.
Patients and Methods From a prospective single center database of 628 patients, 132 patients were aged 60 years or over
and underwent a primary major liver resection. Of these patients, 93 could be matched one-to-one with a control patient,
aged less than 60 years, with the same diagnosis and the same type of liver resection. The mean age difference was
16.7 years.
Results Patients over 60 years of age had a significantly higher American Society of Anaesthesiologists (ASA) grade. All
other demographics and operative characteristics were not different. In-hospital mortality and morbidity were higher in the
patients over 60 years of age (11% versus 2%, p=0.017 and 47% versus 31%, p=0.024). One-, 3-, and 5-year survival rates
in the patients over 60 years of age were 81%, 58%, and 42%, respectively, compared to 90%, 59%, and 42% in the control
patients (p=0.558). Unified model Cox regression analysis showed that resection margin status (hazard ratio 2.51) and ASA
grade (hazard ratio 2.26), and not age, were determining factors for survival.
Conclusion This finding underlines the important fact that in patient selection for major liver resections, ASA grade is more
important than patient age.
Keywords Liver . Surgery . Aged . Survival .
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Introduction
Liver resection is the preferred treatment for a wide
range of primary and secondary liver tumors. Advances
in preoperative assessment, surgical techniques, anesthe-
siology, and postoperative care have progressively low-
ered the perioperative risk of liver resections and thereby
widened operative indications.1–3 This has markedly
increased the number of patients evaluated for liver
resections.4
Besides this, increased life expectancy and improved
general health status lead to an increase in the number of
elderly patients eligible for liver resection.
These developments stress the need to determine the
influence of advanced age on the outcome after liver
resection. Age-associated decline in liver volume, hepatic
blood flow, and regenerative capacity might be responsible
for higher risks associated with liver resections in elderly
patients.5 Nevertheless, several observational cohort studies
addressed this issue and have failed to show age to be an
independent risk factor influencing short- and long-term
survival after liver resections.6–11 These observational
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cohort studies included a mix of wedge, minor, and major
liver resections, and retrospectively compared study groups
based on patient age at the time of liver resection. This
study design may include a selection bias in terms of
diagnosis and magnitude of liver resection.
The aim of this study is to assess the short- and long-
term outcome of liver resections in the elderly in a
matched control analysis. In order to address the short-
comings of the earlier mentioned studies, a homogeneous
cohort of patients undergoing major liver resections for
primary or secondary tumors in otherwise normal liver
parenchyma was chosen.
Patients and Methods
Between December 1978 and December 2006, 628 con-
secutive patients underwent a primary liver resection in our
institution. Their medical data were collected in a database.
The patient variables included patient demographics,
operative data, pathology data, and follow-up data
concerning morbidity and survival. Follow-up was com-
pleted until December 31, 2006.
From this database, 236 patients (37.6%) were over the
age of 60 at the time of liver resection. Of these patients, 74
underwent a resection of less then three Couinaud’s
segments12 and were therefore excluded. A further 30
patients, treated for Klatskin tumors, were also excluded as
this aggressive type of tumor tends to result in a different
short- and long-term outcome compared to other primary or
secondary hepatic malignancies.13,14 Another argument to
exclude patients treated for Klatskin tumors was the
prolonged preoperative cholestasis resulting in parenchymal
changes.
Therefore, the study group consisted of the remaining
132 patients over 60 years of age. Of these patients, 93
could be matched with a control group of patients aged
less than 60 years at the time of liver resection. Patients
were matched on a one-to-one basis with control patients
with the same type of tumor and the same type of liver
resection according to Couinaud segments. In case of
more than one potential match, the control patient who
underwent the liver resection at a date closest to the
operation date of the match was selected in order to
minimize any potential historical bias. All included
patients had non-cirrhotic parenchyma.
An exact match could not be found for 39 patients. The
demographic data of these 39 unmatched patients were
compared with the data of the matched patients to assess a
potential selection bias.
Data about pre- and postoperative treatment protocols
and techniques of liver resections have been published in
earlier reports by this group.13,15
Study Variables
Study variables were age, gender, American Society of
Anaesthesiologists (ASA) score, type of tumor, type of
resection, intraoperative blood transfusions, and resection
margin status. Type of tumor was divided in colorectal
metastasis, hepatocellular carcinoma, or other malignant or
benign tumors. In concordance with recent literature,10
intraoperative blood transfusions were noted as less than
three packed cells or three or more packed cells transfused
peroperatively. Resection margin status was defined as R0
resection when all surgical margins were microscopically
free of tumor cells, R1 resection when tumor cells were
identified on light microscopy in one or more of the
margins, and palliative resection when macroscopic tumor
was left behind in one or more of the margins or outside the
liver. R0 resections were considered radical, and R1 and
palliative resections were considered irradical.
Outcome Parameters
Outcome parameters were patient survival, disease-free
survival, in-hospital mortality, and postoperative morbidity
and reinterventions. Patients with benign tumors and
patients with palliative resections were excluded when
computing disease-free survival. Patient survival was
defined as time between the operation date and the date of
patient death. Surviving patients at the end of the study
period were censored. Disease-free survival was defined as
the time between the operation date and the date of tumor
recurrence. Recurrence was proven histological by imaging
studies or by compelling clinical suspicion. Patients without
evidence for recurrence were censored after the end of the
study period. Mortality was defined as in hospital mortality
during the initial hospitalization for the liver resection.
Postoperative morbidity was assessed by analyzing the
incidence of bleeding, hepatic, biliary, lung, wound, and
infectious complications. Postoperative morbidity was
expressed as the proportion of patients with any of these
complications. The length of postoperative intensive care
unit (ICU) stay, as well as the length of hospital stay, was
recorded.
Study Design and Statistical Methods
In order to assess differences in baseline characteristics
between the matched patients and the control patients,
study variables were compared. Since not all patients over
60 years of age could be matched, a potential selection bias
existed. Therefore, the 93 matched patients and the 39
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unmatched patients were also compared. To assess a
potential historical bias, the difference in operation date
between the matched patients and the control patients was
assessed.
In order to assess differences in outcome between the
matched patients and the control patients, outcome param-
eters were compared. The influence of the study variables
on overall outcome was assessed in a univariate analysis in
a unified model of matched and control patients. Parameters
with a p value <0.10 as well as age, being the parameter of
paramount interest in this study, were entered into a Cox
regression analysis in a backward likelihood manner for
multivariate analysis.
Categorical and continuous variables were compared
using the Pearson chi-square test and the Mann–Whitney U
test where appropriate. Survival analyses were performed
by the Kaplan–Meier method, and comparisons were made
using the log-rank test.16 A significant difference was
defined as a p value <0.05.
Statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS) 14.0 software
package (SPSS Inc., Chicago, IL, USA).
Results
Demographics
Patient demographics and operative characteristics are
shown in Table 1. Mean age difference between the
matched and the control patients was 16.7 years (SD,
9.2 years). The operation date of the matched patients was
on average 1.2 years (SD, 3.4 years) later, compared to the
operation date of the control patients. The difference
between operation dates was below 5 years for 95% of
the matches.
As expected, significant differences between the
matched and the control patients were found regarding
age but also regarding ASA status p<0.001. Since only two
patients were ASA grade 4, grades 3 and 4 were combined
in one group. Of the matched patients, 24% were ASA
grade 3 or 4 versus 8% of the control patients. Of the
control patients, 49% were ASA grade 1 versus 22% of the
matched patients.
Significant differences between the matched and the
unmatched patients were found regarding the type of tumor











Median age range, years 66 (60–82) 52 (19–59) <0.001a 68 (61–78) n.s.a
Gender, n %
Male 49 (53) 55 (59) n.s.a 24 (62) n.s.a
ASA grade, n % <0.001b n.s.b
Grade 1 21 (23) 47 (51) 11 (28)
Grade 2 48 (52) 39 (42) 15 (39)
Grade 3 or 4 24 (26) 7 (8) 12 (31)
Type of disease n.s.b 0.010b
Colorectal metastasis 70 (75) 70 (75) 25 (64)
Hepatocellular Carcinoma 15 (16) 15 (16) 3 (8)
Other malignant disease 3 (3) 3 (3) 7 (18)
Benign disease 5 (5) 5 (5) 4 (10)
Type of resection n.s.b 0.002b
Right trisectionectomy S 4, 5, 6, 7, 8±1 19 (20) 19 (20) 4 (10)
Left trisectionectomy S 2, 3, 4, 5, 8±1 4 (4) 4 (4) 1 (3)
Left hemihepatecomy S 2, 3, 4±1 21 (23) 21 (23) 10 (26)
Right hemihepatectomy S 5, 6, 7, 8±1 49 (53) 49 (53) 18 (46)
Other 3 or more segments 0 0 6 (15)
Resection margin status n.s.b n.s.b
R0 75 (81) 74 (80) 30 (77)
R1 or R2 9 (10) 12 (13) 3 (8)
Benign disease 5 (5) 5 (5) 4 (10)
Missing 4 (4) 2 (2) 2 (5)
Intraoperative blood transfusion n.s.a n.s.a
Three or more RBCs 29 (31) 24 (26) 9 (23)
ASA American Society of Anaesthesiologists
a Pearson chi-square test
b Chi-square test
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p=0.01. Of the matched patients, 16% had hepatocellular
carcinoma HCC versus 8% of the unmatched patients. Of
the unmatched patients, 18% had non-colorectal, non-HCC
malignancies versus 3% of the matched patients. Gender,
resection margin status and intraoperative blood transfusion
were not significantly different between the matched
patients and the unmatched patients.
Short-term Outcome
Matched Versus Control Patients
Short-term outcome parameters are shown in Table 2. In-
hospital mortality was 6.5%. In-hospital mortality was
significantly higher in the matched patients compared to
the control patients 11% versus 2%, p=0.017. Four
matched patients versus one of the control patients died
because of sepsis. Four matched patients died because of
liver insufficiency, compared to one of the control patients.
One matched patient died of massive pulmonary embolism
and another of pulmonary aspiration.
Unified Model Analysis
Patients with ASA grade 1, 2, or 3/4 had an in-hospital
mortality rate of 2.5%, 6.9%, and 14%, respectively p=0.101.
Gender, type of disease, type of resection, intraoperative
blood transfusion, and resection margin status also showed
no significant influence on in-hospital mortality.
Overall postoperative morbidity was 39%. Morbidity
was significantly higher in the matched patients compared
to the control patients 47% versus 31%, p=0.024. Morbidity
was significantly higher after resections of five or more
Couinaud segments compared to resections of three or four
Couinaud segments 59% versus 33%, p=0.002, after three
or more preoperative transfusions compared to less than
three 53% versus 34%, p=0.017, and after radical resections
compared to irradical resections 62% versus 38%, p=0.039.
ASA grade, gender, and type of disease showed no
significant influence on morbidity.
The overall reintervention rate was 22%. Overall median
length of stay in the ICU and hospital were 1 range, 0–45,
and 16 range, 5–116 days, respectively. The reintervention
rate and length of stay in the ICU and hospital were not
significantly different between the matched and the control
patients. The reintervention rate was significantly higher in
male patients compared to female patients 27% versus
15%, 0.043, in patients undergoing resection of five or
more Couinaud segments compared to resections of three
or four Couinaud segments 41% versus 15%, p<0.0005,
and in patients with three or more intraoperative trans-
fusions compared to patients with less than three 32%
versus 17%, p=0.027. ASA grade, type of disease, and
resection margin status showed no significant influence on
morbidity.
Long-term Outcome
Matched Versus Control Patients
One-, 3-, and 5-year survival in the matched patients was
81%, 58%, and 42%, respectively. One-, 3-, and 5-year
survival in the control patients was 90%, 59%, and 42%,
respectively p=0.558; Fig. 1. At the end of the study
period, 49 53% of the matched patients and 45 48% of the
control patients were still alive.











ICU stay, days, mean ± SD 3.6±5.7 3.4±8.7 n.s.b 2.5±2.7 n.s.b
Total hospital stay, days, mean ± SD 20±12 22±17 n.s.b 18±11 n.s.b
Mortality, n % 10 (11) 2 (2) 0.017 3 (8) n.s.
Postoperative morbidity, n %
Overall 44 (47) 29 (31) 0.024 17 (44) n.s.
≤4 segments resected 27/70 (39) 19/70 (27) n.s. 14/34 (41) n.s.
>4 segments resected 17/23 (74) 10/23 (44) 0.036 3/5 (60) n.s.
Reinterventions, n %
Overall 22 (24) 18 (19) n.s. 8 (21) n.s.
≤4 segments resected 10/70 (14) 11/70 (16) n.s. 6/34 (18) n.s.
>4 segments resected 12/23 (52) 7/23 (30) n.s. 2/5 (40) n.s.
a Pearson chi-square test
bMann–Whitney U test
ASA, American Society of Anaesthesiologists
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One-, 3-, and 5-year disease-free survival in the matched
patients was 63%, 45%, and 39%, respectively. One-, 3-,
and 5-year disease-free survival in the control patients was
67%, 35%, and 31%, respectively p=0.468; Fig. 2.
Unified Model Analysis
Patient age, ASA grade, gender, and intraoperative blood
transfusions showed no significant influence on patient
survival. In univariate analysis, colorectal metastatic tumor
or hepatocellular carcinoma, resection of five or more
Couinaud segments, and irradical resection all significantly
correlated with worse patient survival (Table 3).
Patient survival was further analyzed by entering patient
age, ASA grade, type of disease, type of resection, and
resection margin status as covariables in a multivariate
analysis. In Cox regression analysis, resection margin status
and ASA grade proved to be independent predictors of
patient survival (Table 4).
Univariate analysis of disease-free survival in patients
undergoing a radical resection for malignant disease
showed that none of the study variables met the conditions
to be entered in a multivariate analysis.
Discussion
Demographic studies have indicated a marked increase in
life expectancy leading to 19% of the population aged
60 years or over at this moment in Europe and Northern
Figure 1 Patient survival.
Figure 2 Disease-free survival.
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America, Australia/New Zealand, and Japan. This figure is
expected to increase to 33% in 2050 (http://www.un.org/
esa/population/publications/aging99/fa99.htm). Epidemio-
logic surveys show over 50% of primary and secondary
hepatic malignancies to occur in patients over 65 years
(http://seer.cancer.gov), and liver surgery is the mainstay of
curative treatment for these tumors.17 It is therefore
important to assess the influence of age on outcome after
liver surgery. Previous studies addressing this issue have
compared cohorts of elderly patients with younger patients
treated in the same time period (Table 5).6–11,18 However,
comparing cohorts introduces a potential selection bias due
to heterogeneity of patients and operative characteristics. In
order to maximally reduce selection bias in this study, a
matched control analysis was performed to ensure com-
parison of elderly and younger patients with the same
diagnosis and the same extent of liver resection. Only non-
cirrhotic patients undergoing a primary liver resection of
three or more Couinaud segments were included.
A cutoff point at 70 years of age at the time of liver
resection would allow for only 31 patients to be matched
one-on-one to a control patient with the same type of liver
resection for the same diagnosis. Including such a small
number of patients would lead to an underpowered study.
With a cutoff point for elderly and younger patients at
60 years of age at the time of liver resection, 93 of the
patients over 60 years of age could be matched, which is over
70% of the patients over 60 years of age from this series. This
was an important argument in an always arbitrary choice of a
cutoff point for elderly and younger patients. The matched
patients were not different from the unmatched patients
with regard to age, gender, ASA grade, resection margin
status, and intraoperative blood transfusions.
Hepatocellular carcinoma was more common in the
matched patients, whereas non-colorectal, non-hepatocellular
carcinoma was more common in the unmatched patients. This
difference results from the fact that these non-colorectal, non-
hepatocellular carcinoma have their peak incidence in patients
over 60 years of age, so only for a minority of these patients a
matching younger control patient could be found.
Mean age difference between the matched patients and
the control patients was over 16 years, indicating a
clinically relevant age difference. The mean difference in
operation date was only 1.2 years, and for 95% of the
matches, this difference was below 5 years, showing that no
relevant historical bias was introduced.
Besides the obvious difference in age between the
matched and the control patients, a significant difference
regarding ASA grade was found. A higher proportion of
matched patients were ASA grade 3 and a higher
proportion of control patients were ASA grade 1. This
was the only significant difference in baseline charac-
teristics between the matched and the control patients.
However, higher ASA grade could not be significantly
correlated to a worse short-term outcome in terms of
postoperative morbidity or in-hospital mortality, whereas
age above 60 years was related to worse short-term
outcome. Patients in ASA grade 3 are particularly repre-
sented among the subgroup of patients aged less then
60 years, since a patient over 60 years of age with ASA
grade 3 will be more often deemed inoperable compared to
a younger patient with ASA grade 3. This selection bias
regarding ASA grade might explain the fact that a relation
between ASA grade and short-term outcome could not be
found in these series.
Short-term outcome was worse in matched patients
compared to the control patients. Matched patients had a
significantly higher in-hospital mortality rate (11%) com-
pared to control patients (2%) in this study. In both of the
control patients and in eight out of ten matched patients, the
in-hospital mortality was due to liver insufficiency and
sepsis.
The key to explaining the difference in in-hospital
mortality might be a slower regeneration rate in patients
over 60 years of age, making these patients more prone to
liver insufficiency and sepsis. Liver regeneration occurs by
inducing hyperplasia in the remnant liver volume. The
initiation and synchronization of this regeneration response
depends on the extent of liver resection. A substantially
higher cellular replication rate is seen after major liver
resection compared to minor liver resection.19,20 An
Table 4 Multivariate Analysis of Predictors of Patient Survival
p value Hazard ratio 95% CI
Resection margin
Radical
Irrradical 0.002 2.44 (1.34–4.42)
ASA
Grade 1
Grade 2 0.084 1.61 (0.97–2.66)
Grades 3 or 4 0.016 2.21 (1.16–4.22)
Age
<60 years
≥60 years 0.213 1.01 (0.99–1.04)





Type of disease 0.041
Type of resection minor/major 0.022
Intraoperative blood transfusion <3/3+ RBCs 0.085
Resection margin status 0.002
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excellent summary of the molecular basis of this process
has recently been described by Clavien et al.21 Animal
studies show the process of regeneration to be dependant of
mediators similar to those found in acute inflammation.
Mediators identified in the process of initiating the cell
cycle are cytokines derived from Kupfer cells like tumor
necrosis factor α and interleukin-6. After activation of the
cell cycle, growth factors like epidermal growth factor,
hepatocyte growth factor, transforming growth factor α and
β, and other factors like platelet-derived serotonin and bile
acids induce, maintain, and finally, terminate a full and
synchronized regeneration phase. Lower expression of
these mediators in patients over 60 years of age might
impair the process of liver regeneration and thereby
increase the risk of inadequate recovery of liver volume
and lead to higher risks of clinical signs of liver failure after
liver resection.
A previous study already showed a correlation between
patient age and the risk of liver failure after primary liver
resection.22 Shimada et al. more recently showed a
correlation between higher patient age and slower regenera-
tion rate after right hemihepatectomy in humans.23 In
humans, no comparative studies regarding regeneration rate
after hepatectomy in elderly versus younger patients have
been performed, but Biondo-Simoes et al. recently showed
a relevant delay in regeneration rate after major hepatectomy
in elderly compared to younger rats.24 Slower regeneration
rates might well explain the higher in-hospital mortality,
mostly due to liver insufficiency and sepsis, in patients over
60 years of age.
Despite significantly higher in-hospital mortality in the
matched patients, 5-year patient survival was 42% in both
groups, and 5-year disease-free survival was 39% in the
matched and 31% in younger patients, respectively. These
figures are concordant with recent studies showing 5-year
patient survival rates of 30% to 49% in elderly patients
compared to 32% to 53% in younger patients. This means
that, despite the difference regarding short-term outcome,
patients over 60 years of age show no difference in long-
term outcome compared to younger patients. This suggests
a relatively worse long-term prospect for younger patients
surviving the hospitalization phase of a liver resection
compared to patients over 60 years of age surviving this
phase. While from previous literature it might already been
known that long-term outcome is not different between
elderly and younger patients, a new observation from this
study is the paradox in survival patterns. Younger patients
may show a far better in-hospital survival, but in the end, it
still leads to the same prospects in terms of long-term
survival compared to patients over 60 years of age. In
return, the patient over 60 years of age has a higher risk of
in-hospital mortality, but this is compensated by a relatively
better prospect in terms of long-term survival, which might
be due to less aggressive tumor biology in these patients.
However, survival analysis showed no difference in patient
survival or disease-free survival between younger patients
surviving the hospitalization phase of a liver resection
compared to patients over 60 years of age surviving the
hospitalization phase of a liver resection in our population
(data not shown).
Multivariate analysis shows the resection margin status
and ASA grade to be independent predictors of long-term
patient survival. As indicated in Table 4, ASA grades 3 or 4
patients have an increased chance of long-term mortality
compared to ASA grade 1 patients with a hazard ratio of
2.21. Age itself was not an independent predictor of long-
term survival.
This finding underlines the obvious statement to strive
for tumor-free margins, but it also urges those involved in
preoperative patient selection for major liver resections
rather to consider the ASA grade than patient age as a
predictive factor for long-term survival.
Conclusion
The influence of advanced age on the outcome after liver
resection has never been explored in a matched control
study. The current study paradoxically shows a worse short-
term outcome in patients over 60 years of age in terms of in-
Table 5 Literature Reports
Group Year Country Number of patients 3-year survival % 5-year survival %
<70 years >70 years <70 years >70 years
CRM Mazzoni et al. 2007 Italy 144 versus 53 38 30
Nagano et al. 2005 Japan 150 versus 62 53 34
HCC Ferrero et al. 2005 Italy 177 versus 64 32 49
Hanazaki et al. 2001 Japan 283 versus 103 40 42
All indications Menon et al. 2006 UK 390 versus 127 57 59
Cescon et al. 2003 Italy 99 versus 23 54 64
CRM colorectal metastasis, HCC hepatocellular carcinoma
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hospital mortality and morbidity, while their overall long-
term survival is not different from control patients. This
observation confirms the clinical observation that patients
over 60 years of age have higher risks after liver resections,
while at the same time, this does not result in a difference in
long-term outcome. Multivariate analysis shows tumor-free
resection margins and lower ASA grade to be independent
predictors of long-term patient survival, while age itself was
not associated with long-term patient survival.
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